Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted TherapyCatherine G. Tran(University of Iowa), Po Hien Ear(University of Iowa)Preprints.orgFebruary 7, 202210.20944/preprints202202.0090.v1Cited by 5SaveCiteExport RISWatch citationsRelated PapersEstablishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy|Cancers|2022|22A luminescent sensor for investigating serotonin metabolism in neuroendocrine cancer|Surgery|2023|3